The Trump administration has finalized a plan to eliminate federal Medicaid funding for gender-affirming care for transgender youths. This rule specifically targets hormone therapy, puberty blockers, and surgeries for this population. While federal funding will cease on October 13th, states can still use their own funds to cover these services. Psychotherapy for gender dysphoria remains eligible for federal funding. The administration justifies this policy by citing concerns about the perceived harm of these procedures to children. They reference a report suggesting weak evidence for pediatric gender-affirming medical interventions. However, major medical organizations disagree, stating this report misrepresents the medical consensus. These groups, including the American Medical Association, consider transition-related care safe and appropriate for transgender youth. LGBTQ+ advocates have condemned the rule as a dangerous restriction on medically necessary care. They argue it hinders transgender and nonbinary youth from accessing essential healthcare. The administration claims the goal is to protect children, not to save money.